Loblaw Companies Limited · TSX:L
Loblaw Companies — Q2 2023 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Jul 26, 2023
Slide 1: Supplementary Slides Q2 2023
SUPPLEMENTARY SLIDES Q2 2023 For the periods ended June 17, 2023 and June 18, 2022 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q2 2023 (In CAD millions unless otherwise noted) Q2 2023 Q2 2022 % Change (1) Consolidated Revenue $13,738 $12,847 ↑ +6.9% Adjusted EBITDA $1,640 $1,499 ↑ +9.4% Adjusted EBITDA Margin 11.9% 11.7% ↑ 20 bps Adjusted Net Earnings Avaliable to Common Shareholders $62
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q2 2023 (In CAD millions unless otherwise noted) Q2 2023 Q2 2022 % Change (1) Total Retail Revenue $13,471 $12,623 ↑ 6.7% Retail Revenue - Food $9,560 $8,981 ↑ 6.4% Retail Revenue - Drug $3,911 $3,642 ↑ 7.4% Pharmacy and Healthcare Services $1,984 $1,813 ↑ 9.4%
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q2 2023 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +6.1% Basket Size(2) ↓ Traffic(2) ↑ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +5.7